State Of Wisconsin Investment Board Aclaris Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $46,267 - $77,230	7,053 Added 18.77%	44,627 $305,000
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $15,353 - $20,705	-1,946 Reduced 4.92%	37,574 $389,000
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $31,115 - $78,997	-4,401 Reduced 10.02%	39,520 $319,000
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $41,284 - $52,923	-2,881 Reduced 6.16%	43,921 $691,000
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $21,382 - $29,807	-1,636 Reduced 3.38%	46,802 $737,000
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $79,877 - $134,282	-7,862 Reduced 13.96%	48,438 $676,000
Q2 2021 Aug 12, 2021	BUY	$17.08 - $29.6 $961,603 - $1.67 Million	56,300 New	56,300 $989,000
Q3 2019 Nov 12, 2019	SELL	$0.79 - $2.47 $29,072 - $90,896	-36,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $1,704 - $5,648	800 Added 2.22%	36,800 $81,000
Q1 2019 May 13, 2019	BUY	$5.63 - $7.84 $46,166 - $64,288	8,200 Added 29.5%	36,000 $216,000
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $184,064 - $267,392	12,800 Added 85.33%	27,800 $404,000
Q3 2017 Nov 01, 2017	BUY	$23.02 - $28.8 $345,300 - $432,000	15,000	15,000 $387,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.